...
首页> 外文期刊>Journal of Clinical Microbiology >Phylogenetic Analysis of Invasive Serotype 1 Pneumococcus in South Africa, 1989 to 2013
【24h】

Phylogenetic Analysis of Invasive Serotype 1 Pneumococcus in South Africa, 1989 to 2013

机译:1989年至2013年南非侵袭性1型肺炎球菌的系统发育分析

获取原文
           

摘要

Serotype 1 is an important cause of invasive pneumococcal disease in South Africa and has declined following the introduction of the 13-valent pneumococcal conjugate vaccine in 2011. We genetically characterized 912 invasive serotype 1 isolates from 1989 to 2013. Simpson's diversity index (D) and recombination ratios were calculated. Factors associated with sequence types (STs) were assessed. Clonal complex 217 represented 96% (872/912) of the sampled isolates. Following the introduction of the 13-valent pneumococcal conjugate vaccine (PCV13), ST diversity increased in children <5 years (D, 0.39 to 0.63, P = 0.002) and individuals >14 years (D, 0.35 to 0.54, P < 0.001): ST-217 declined proportionately in children <5 years (153/203 [75%] versus 21/37 [57%], P = 0.027) and individuals >14 years (242/305 [79%] versus 96/148 [65%], P = 0.001), whereas ST-9067 increased (4/684 [0.6%] versus 24/228 [11%], P < 0.001). Three subclades were identified within ST-217: ST-217C1 (353/382 [92%]), ST-217C2 (15/382 [4%]), and ST-217C3 (14/382 [4%]). ST-217C2, ST-217C3, and single-locus variant (SLV) ST-8314 (20/912 [2%]) were associated with nonsusceptibility to chloramphenicol, tetracycline, and co-trimoxazole. ST-8314 (20/912 [2%]) was also associated with increased nonsusceptibility to penicillin (P < 0.001). ST-217C3 and newly reported ST-9067 had higher recombination ratios than those of ST-217C1 (4.344 versus 0.091, P < 0.001; and 0.086 versus 0.013, P < 0.001, respectively). Increases in genetic diversity were noted post-PCV13, and lineages associated with antimicrobial nonsusceptibility were identified.
机译:血清型1是南非侵袭性肺炎球菌疾病的重要原因,并且在2011年引入13价肺炎球菌结合疫苗后有所下降。我们对1989年至2013年间的912侵袭性血清型1分离株进行了遗传学鉴定。Simpson的多样性指数(D)和计算重组率。评估与序列类型(ST)相关的因素。克隆复合物217代表了采样分离物中的96%(872/912)。引入13价肺炎球菌结合疫苗(PCV13)后,<5岁儿童(D,0.39至0.63, P = 0.002)和> 14岁儿童(D,0.35)的ST多样性增加降至0.54, P <0.001):<5岁儿童的ST-217比例下降(153/203 [75%]对21/37 [57%], P = 0.027)和大于14岁的个人(242/305 [79%]对96/148 [65%], P = 0.001),而ST-9067有所增加(4/684 [0.6%])对比24/228 [11%], P <0.001)。在ST-217中识别出三个子小节:ST-217 C1 (353/382 [92%]),ST-217 C2 (15/382 [4%]) ,和ST-217 C3 (14/382 [4%])。 ST-217 C2 ,ST-217 C3 和单基因座变异体(SLV)ST-8314(20/912 [2%])与氯霉素的不敏感性相关,四环素和复方新诺明。 ST-8314(20/912 [2%])也与对青霉素的不敏感性增加有关( P <0.001)。 ST-217 C3 和新近报道的ST-9067的重组率比ST-217 C1 高(4.344对0.091, P <0.001 ;分别为0.086和0.013, P <0.001)。在PCV13之后发现了遗传多样性的增加,并鉴定了与抗菌药不敏感性相关的血统。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号